Skip to main content
Caplight Logo









Onya Therapeutics

Onya Therapeutics

Private
Ebbw ValeHealthcare & Life Scienceshttps://onya.bio/

Last Round

Seed

Nov 1, 2025

Total Funding Raised

$3.42M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Onya Therapeutics is a biotechnology company that develops investigational pharmaceutical treatments for chronic and acute wounds.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Non-AI

Keywords

protein therapeuticstunable therapeuticsreversible therapeuticsswitchable biologicsbiologics platformsmall molecule controldrug toxicity reductiondrug discovery platformoncologyrare diseasesbiotech partnershipspreclinical biotechnologydrug licensingpharmaceutical patchwound care

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Onya Therapeutics Comparables

Compare Onya Therapeutics with similar companies based on industry and business-model similarity.

Onya Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
LightOx Ltd
67%
Mariposa Therapeutics
60%
Ilya Pharma
56%

Onya Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedNov 1, 2025

Key People

Founding team and executive leadership

Thomas Hafner

Founder & CEO

Founding Team

Rachael McInnes

Chief Operating Officer

Executive Team

Onya Therapeutics Investors

Notable investors and investment history

Onya Therapeutics investors
InvestorRounds
South East AngelsSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 151% MoM, reaching 3.8K.

  • Nov 1, 2025

    $3.4M round led by South East Angels

Onya Therapeutics Filings

Explore SEC and related filing metadata, where available.

Onya Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Onya Therapeutics's valuation, stock price, and market status.

Is Onya Therapeutics a public or private company?

Onya Therapeutics is a private company.

What is the current stock price of Onya Therapeutics?

Onya Therapeutics is a private company with no public stock price. No recent secondary market data is available.

How much is Onya Therapeutics worth (valuation)?

Valuation information for Onya Therapeutics is not publicly available.

Can I buy Onya Therapeutics stock?

Onya Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Onya Therapeutics's last funding round?

Funding round information for Onya Therapeutics is not publicly available.

Who are the main investors in Onya Therapeutics?

Investor information for Onya Therapeutics is not publicly disclosed.

Will Onya Therapeutics IPO soon?

No public IPO plans have been announced for Onya Therapeutics.

How can I track Onya Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Onya Therapeutics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersEbbw Vale
Employee Range12
Year Founded2020
Last FundingNov 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?